Matthias Alder

Mr., Autolus Therapeutics

Matthias Alder joined Autolus as Chief Business Officer in July 2017. Previously, he served as EVP, BD&L and General Counsel of Sucampo Pharmaceuticals Inc. During his tenure at Sucampo, Matthias established a late stage development pipeline in orphan and rare diseases through acquisitions and strategic collaborations. Earlier in his career, he served as EVP Corporate Development and Legal Affairs at Cytos Biotechnology AG, and as SVP Administration and General Counsel of Micromet, Inc. Prior to Micromet, he was a partner in the Life Sciences Transactions Practice at Cooley LLP.